Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Nat Commun
; 14(1): 2744, 2023 05 12.
Article
in En
| MEDLINE
| ID: mdl-37173324
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunotherapy
/
Neoplasms
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom